Add BrightSurf on Google Email

Overactive microRNAs block fat cell development in progeria

A new study found that miR-145-5p and miRNA-27b-3p interfere with fat cell formation in children with Hutchinson-Gilford progeria syndrome, a rare and fatal premature aging disorder. These microRNAs silence genes required for fat cell growth and function, suggesting they could be a promising therapeutic strategy to restore fat tissue.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateOct 7, 2025

PLOS announces a new publishing agreement in India

The Public Library of Science (PLOS) has partnered with the Manipal Academy of Higher Education (MAHE) in India, allowing MAHE researchers to publish unlimited in all PLOS journals through 2026. This agreement shifts publishing costs from authors to research institutions, promoting open access and barrier-free publishing.

SourcePLOS·TypeNews article·DateSep 30, 2025

New study links exosomes to biological aging

Researchers found that exosomes from senescent cells and circulatory exosomes carry molecular signatures associated with biological aging and cellular senescence. These signatures include proteins, lipids, and microRNAs linked to inflammation, oxidative stress, and tissue remodeling.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateSep 2, 2025

Exercise may slow epigenetic aging

A new study suggests that regular exercise can influence epigenetic aging and potentially reverse it, offering a promising way to extend healthspan. Physical fitness is closely associated with slower epigenetic aging, and sedentary behavior may have detrimental effects on the body's internal aging process.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateAug 12, 2025

Study identifies key genetic alterations and biomarker for blastic plasmacytoid dendritic cell neoplasm

A recent study discovered that the mutational landscape of blastic plasmacytoid dendritic cell neoplasm (BPDCN) is similar to other myeloid neoplasms. The researchers identified CCDC50 as a potential biomarker for this disease, which showed promising results in tracking disease activity and monitoring treatment success.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateJul 7, 2025

WIN International Molecular Tumor Board recommends tailored treatment for advanced colorectal cancer

A new precision oncology paper presents a case of a 62-year-old man with metastatic colorectal cancer who underwent multiple lines of therapy. The WIN International Molecular Tumor Board proposed personalized treatment plans based on the tumor's unique genetic mutations, highlighting the growing role of precision oncology in guiding th...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateJun 24, 2025